glp 1 and 2 GLP-1 receptor agonists are increasingly used to treat type diabetes obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read GLP-1 and GLP-2 Orchestrate Intestine

Reduced Appetite to the Point of Food Aversion Some users report a near total disinterest in food, which can lead to inadequate protein intake, dehydration, or electrolyte imbalance if not managed carefully

Si la prioridad son las pruebas cientficas, los suplementos orales tienen una clara ventaja

The median follow-up period for the entire cohort was 2.3 years

Similar cAMP-mediated mechanisms may occur in GLP-1 receptive neurons, but more research is needed Figure 1

Medication selection, including whether compounded options are used, is decided by the prescribing clinician

GLP-1s are also identified to be the fastest growing drug category by total spending in the US market